The NIDDK Hematology Centers Program is providing a novel support mechanism for researchers to pursue new directions in non-malignant hematology.  New Type B Pilot and Feasibility Funding applications will be accepted through September 16, 2024, 5:00pm MT. 

Yale Center of Excellence in Hematology Director Diane Krause, MD, PhD is speaking for the Max Wintrobe Endowed Lecture “Mechanisms of Hematopoietic Fate Specification to Megakaryocytes”